PDS Biotechnology
PDSB
PDSB
47 hedge funds and large institutions have $9.79M invested in PDS Biotechnology in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less funds holding
Funds holding: 51 → 47 (-4)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
Holders
47
Holding in Top 10
–
Calls
$315K
Puts
$2K
Top Buyers
| 1 | +$5.26M | |
| 2 | +$239K | |
| 3 | +$119K | |
| 4 |
IGGA
Iron Gate Global Advisors
Nsl,
Utah
|
+$89.3K |
| 5 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
+$33.9K |
Top Sellers
| 1 | -$359K | |
| 2 | -$263K | |
| 3 | -$163K | |
| 4 |
Two Sigma Investments
New York
|
-$107K |
| 5 |
Millennium Management
New York
|
-$90.2K |